ArticleMolecular therapy. Oncology2026

A tri-component organoid model reveals field-cancerized fibroblasts as key drivers of LUAD recurrence and drug resistance.

Kun Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.